{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:47:02Z","timestamp":1782863222734,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10147-026-02983-7","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T03:00:49Z","timestamp":1770865249000},"page":"695-702","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevention of hepatitis B virus reactivation according to hepatitis B surface antigen status in patients receiving systemic chemotherapy in Japan using an electronic medical record database"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3616-2794","authenticated-orcid":false,"given":"Masakatsu","family":"Hattori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6084-9845","authenticated-orcid":false,"given":"Kayoko","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7309-5627","authenticated-orcid":false,"given":"Munenori","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3411-9427","authenticated-orcid":false,"given":"Satomi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7477-4071","authenticated-orcid":false,"given":"Koji","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"2983_CR1","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/phar.2340","volume":"39","author":"DJ Smalls","year":"2019","unstructured":"Smalls DJ, Kiger RE, Norris LB et al (2019) Hepatitis B virus reactivation: risk factors and current management strategies. Pharmacotherapy 39:1190\u20131203. https:\/\/doi.org\/10.1002\/phar.2340","journal-title":"Pharmacotherapy"},{"key":"2983_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.7326\/m15-1121","volume":"164","author":"S Paul","year":"2016","unstructured":"Paul S, Saxena A, Terrin N et al (2016) Hepatitis B virus reactivation and prophylaxis during solid tumor chemotherapy: a systematic review and meta-analysis. Ann Intern Med 164:30\u201340. https:\/\/doi.org\/10.7326\/m15-1121","journal-title":"Ann Intern Med"},{"key":"2983_CR3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.gastha.2023.06.014","volume":"3","author":"K Roma","year":"2024","unstructured":"Roma K, Chandler T-M, Dossaji Z et al (2024) A review of the systemic manifestations of hepatitis B virus infection, hepatitis D virus, hepatocellular carcinoma, and emerging therapies. Gastro Hep Adv 3:276\u2013291. https:\/\/doi.org\/10.1016\/j.gastha.2023.06.014","journal-title":"Gastro Hep Adv"},{"key":"2983_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68021-2","volume":"10","author":"M Tatemichi","year":"2020","unstructured":"Tatemichi M, Furuya H, Nagahama S et al (2020) A nationwide cross-sectional survey on hepatitis B and C screening among workers in Japan. Sci Rep 10:11435. https:\/\/doi.org\/10.1038\/s41598-020-68021-2","journal-title":"Sci Rep"},{"key":"2983_CR5","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/hepr.13504","volume":"50","author":"Drafting Committee for Hepatitis Management Guidelines, the Japan Society of Hepatology","year":"2020","unstructured":"Drafting Committee for Hepatitis Management Guidelines, the Japan Society of Hepatology (2020) Japan Society of Hepatology guidelines for the management of hepatitis B virus infection: 2019 update. Hepatol Res 50:892\u2013923. https:\/\/doi.org\/10.1111\/hepr.13504","journal-title":"Hepatol Res"},{"key":"2983_CR6","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.jhep.2022.07.003","volume":"77","author":"GV Papatheodoridis","year":"2022","unstructured":"Papatheodoridis GV, Lekakis V, Voulgaris T et al (2022) Hepatitis B virus reactivation associated with new classes of immunosuppressants and immunomodulators: a systematic review, meta-analysis, and expert opinion. J Hepatol 77:1670\u20131689. https:\/\/doi.org\/10.1016\/j.jhep.2022.07.003","journal-title":"J Hepatol"},{"key":"2983_CR7","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1080\/14787210.2017.1309291","volume":"15","author":"M-Y Zhang","year":"2017","unstructured":"Zhang M-Y, Zhu G-Q, Zheng J-N et al (2017) Nucleos(t)ide analogues for preventing HBV reactivation in immunosuppressed patients with hematological malignancies: a network meta-analysis. Expert Rev Anti-Infect Ther 15:503\u2013513. https:\/\/doi.org\/10.1080\/14787210.2017.1309291","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"2983_CR8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.5604\/16652681.1202910","volume":"15","author":"C Yang","year":"2016","unstructured":"Yang C, Qin B, Yuan Z et al (2016) Meta-analysis of prophylactic entecavir or lamivudine against hepatitis B virus reactivation. Ann Hepatol 15:501\u2013511. https:\/\/doi.org\/10.5604\/16652681.1202910","journal-title":"Ann Hepatol"},{"key":"2983_CR9","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1007\/s10147-016-0995-8","volume":"21","author":"M Ikeda","year":"2016","unstructured":"Ikeda M, Yamamoto H, Kaneko M et al (2016) Screening rate for hepatitis B virus infection in patients undergoing chemotherapy in Japan. Int J Clin Oncol 21:1162\u20131166. https:\/\/doi.org\/10.1007\/s10147-016-0995-8","journal-title":"Int J Clin Oncol"},{"key":"2983_CR10","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1002\/jmv.25540","volume":"91","author":"S Imai","year":"2019","unstructured":"Imai S, Yamana H, Inoue N et al (2019) Validity of administrative database detection of previously resolved hepatitis B virus in Japan. J Med Virol 91:1944\u20131948. https:\/\/doi.org\/10.1002\/jmv.25540","journal-title":"J Med Virol"},{"key":"2983_CR11","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s10147-020-01655-4","volume":"25","author":"S Yazaki","year":"2020","unstructured":"Yazaki S, Yamauchi T, Higashi T (2020) High hepatitis B virus screening rate among patients receiving systemic anticancer treatment in Japan. Int J Clin Oncol 25:1327\u20131333. https:\/\/doi.org\/10.1007\/s10147-020-01655-4","journal-title":"Int J Clin Oncol"},{"key":"2983_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10620-017-4850-1","volume":"63","author":"YE Kwak","year":"2018","unstructured":"Kwak YE, Stein SM, Lim JK (2018) Practice patterns in hepatitis B virus screening before cancer chemotherapy in a major US hospital network. Dig Dis Sci 63:61\u201371. https:\/\/doi.org\/10.1007\/s10620-017-4850-1","journal-title":"Dig Dis Sci"},{"issue":"5","key":"2983_CR13","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.cgh.2014.10.032","volume":"13","author":"C-I Wi","year":"2015","unstructured":"Wi C-I, Loo NM, Larson JJ et al (2015) Low level of hepatitis B virus screening among patients receiving chemotherapy. Clin Gastroenterol Hepatol 13(5):970\u2013975. https:\/\/doi.org\/10.1016\/j.cgh.2014.10.032","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2983_CR14","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2183\/pjab.98.026","volume":"98","author":"S Yoshida","year":"2022","unstructured":"Yoshida S, Takeuchi M, Tanaka-Mizuno S et al (2022) Clinical epidemiology and pharmacoepidemiology studies with real-world databases. Proc Jpn Acad Ser B Phys Biol Sci 98:517\u2013528. https:\/\/doi.org\/10.2183\/pjab.98.026","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"2983_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.37737\/ace.24009","volume":"6","author":"Y Okumura","year":"2024","unstructured":"Okumura Y, Fujiwara T, Tokumasu H et al (2024) A new electronic medical record database linked to claims data and discharge abstract data (the RWD database) in Japan: study design and profile. Ann Clin Epidemiol 6:58\u201364. https:\/\/doi.org\/10.37737\/ace.24009","journal-title":"Ann Clin Epidemiol"},{"key":"2983_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.37737\/ace.24006","volume":"6","author":"K Sakoda","year":"2024","unstructured":"Sakoda K, Mizuno K, Seki T et al (2024) Treatment for patients with autosomal dominant polycystic kidney disease in the chronic kidney disease without kidney replacement therapy in real-world clinical practice: a descriptive retrospective cohort study. Ann Clin Epidemiol 6:33\u201341. https:\/\/doi.org\/10.37737\/ace.24006","journal-title":"Ann Clin Epidemiol"},{"key":"2983_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-024-03550-w","volume":"25","author":"A Hayashi","year":"2024","unstructured":"Hayashi A, Mizuno K, Shinkawa K et al (2024) Effect of multidisciplinary care on diabetic kidney disease: a retrospective cohort study. BMC Nephrol 25:114. https:\/\/doi.org\/10.1186\/s12882-024-03550-w","journal-title":"BMC Nephrol"},{"key":"2983_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2188\/jea.je20200288","volume":"31","author":"K Hayashida","year":"2021","unstructured":"Hayashida K, Murakami G, Matsuda S et al (2021) History and profile of Diagnosis Procedure Combination (DPC): development of a real data collection system for acute inpatient care in Japan. J Epidemiol 31:1\u201311. https:\/\/doi.org\/10.2188\/jea.je20200288","journal-title":"J Epidemiol"},{"key":"2983_CR19","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1093\/jjco\/hyab036","volume":"51","author":"A Okuyama","year":"2021","unstructured":"Okuyama A, Tsukada Y, Higashi T (2021) Coverage of the hospital-based cancer registries and the designated cancer care hospitals in Japan. Jpn J Clin Oncol 51:992\u2013998. https:\/\/doi.org\/10.1093\/jjco\/hyab036","journal-title":"Jpn J Clin Oncol"},{"key":"2983_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7201a1","volume":"72","author":"EE Conners","year":"2023","unstructured":"Conners EE, Panagiotakopoulos L, Hofmeister MG et al (2023) Screening and testing for hepatitis B Virus Infection: CDC recommendations\u2014United States, 2023. MMWR Recomm Rep 72:1\u201325. https:\/\/doi.org\/10.15585\/mmwr.rr7201a1","journal-title":"MMWR Recomm Rep"},{"key":"2983_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/cld.728","volume":"12","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok ASF, McMahon BJ et al (2018) Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Clin Liver Dis 12:33\u201334. https:\/\/doi.org\/10.1002\/cld.728","journal-title":"Clin Liver Dis"},{"key":"2983_CR22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver (2017) EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol 67:370\u2013398. https:\/\/doi.org\/10.1016\/j.jhep.2017.03.021","journal-title":"J Hepatol"},{"key":"2983_CR23","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1111\/hepr.14056","volume":"54","author":"K Okada","year":"2024","unstructured":"Okada K, Nakayama Y, Xu J et al (2024) A nation-wide medical record database study: value of hepatitis B surface antigen loss in chronic hepatitis B patients in Japan. Hepatol Res 54:1004\u20131015. https:\/\/doi.org\/10.1111\/hepr.14056","journal-title":"Hepatol Res"},{"key":"2983_CR24","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1007\/s40121-024-00997-0","volume":"13","author":"Y Tanaka","year":"2024","unstructured":"Tanaka Y, Nakamoto D, Piao Y et al (2024) Implementation of guideline-based HBV reactivation management in patients with chronic HBV infections of HBsAg or resolved HBV infection undergoing immunosuppressive therapy. Infect Dis Ther 13:1607\u20131620. https:\/\/doi.org\/10.1007\/s40121-024-00997-0","journal-title":"Infect Dis Ther"},{"key":"2983_CR25","doi-asserted-by":"publisher","first-page":"719","DOI":"10.11236\/jph.62.12_719","volume":"62","author":"H Tanaka","year":"2015","unstructured":"Tanaka H, Katanoda K (2015) Geographic pattern of hospital selection among cancer inpatients in Japan: a focus on secondary healthcare service areas and designated regional cancer hospitals. Nihon Koshu Eisei Zasshi 62:719\u2013728. https:\/\/doi.org\/10.11236\/jph.62.12_719","journal-title":"Nihon Koshu Eisei Zasshi"},{"key":"2983_CR26","unstructured":"Pharmaceuticals and Medical Devices Agency (2011) Hepatitis B viral growth associated with the use ofdrugs with immunosuppressive effects. In: PMDA Alert for Proper Use of Drugs. https:\/\/www.pmda.go.jp\/files\/000153777.pdf. Accessed 11 Feb 2025"},{"key":"2983_CR27","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1186\/s13063-019-3847-9","volume":"20","author":"T Seki","year":"2019","unstructured":"Seki T, Aki M, Kawashima H et al (2019) Electronic health record nested pragmatic randomized controlled trial of a reminder system for serum lithium level monitoring in patients with mood disorder: KONOTORI study protocol. Trials 20:706. https:\/\/doi.org\/10.1186\/s13063-019-3847-9","journal-title":"Trials"},{"key":"2983_CR28","doi-asserted-by":"publisher","DOI":"10.2196\/40595","volume":"25","author":"T Seki","year":"2023","unstructured":"Seki T, Aki M, Furukawa TA et al (2023) Electronic health record-nested reminders for serum lithium level monitoring in patients with mood disorder: randomized controlled trial. J Med Internet Res 25:e40595. https:\/\/doi.org\/10.2196\/40595","journal-title":"J Med Internet Res"},{"key":"2983_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s40780-015-0030-7","volume":"1","author":"A Sanagawa","year":"2015","unstructured":"Sanagawa A, Kuroda J, Shiota A et al (2015) Outcomes of the implementation of the computer-assisted HBView system for the prevention of hepatitis B virus reactivation in chemotherapy patients: a retrospective analysis. J Pharm Health Care Sci 1:29. https:\/\/doi.org\/10.1186\/s40780-015-0030-7","journal-title":"J Pharm Health Care Sci"},{"key":"2983_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-024-08750-6","volume":"32","author":"C Marty","year":"2024","unstructured":"Marty C, Adam J-P, Martel-Laferri\u00e8re V et al (2024) Impact of universal hepatitis B virus (HBV) screening using chemotherapy orders on the HBV reactivation in cancer patients. Support Care Cancer 32:541. https:\/\/doi.org\/10.1007\/s00520-024-08750-6","journal-title":"Support Care Cancer"},{"key":"2983_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae571","volume":"11","author":"RJ Wong","year":"2024","unstructured":"Wong RJ, Jain MK, Niu B et al (2024) Sociodemographic disparities in hepatitis B treatment: a real-world analysis of 3 safety-net health systems in the United States. Open Forum Infect Dis 11:ofae571. https:\/\/doi.org\/10.1093\/ofid\/ofae571","journal-title":"Open Forum Infect Dis"}],"updated-by":[{"DOI":"10.1007\/s10147-026-03107-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000}}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-02983-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-026-02983-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-02983-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:50:09Z","timestamp":1782859809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-026-02983-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2983"],"URL":"https:\/\/doi.org\/10.1007\/s10147-026-02983-7","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"6 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the Abstract section of this article, the value \u2018reaching 27.1% in 2020\u2019 should have read \u2018reaching 34.0% in 2020\u2019.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10147-026-03107-x","URL":"https:\/\/doi.org\/10.1007\/s10147-026-03107-x","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Masakatsu Hattori is an employee of Real World Data Co., Ltd. Kayoko Mizuno was employed by the Department of Digital Health and Epidemiology, with support from Eisai Co., Ltd. and Kyowa Kirin Co., Ltd. Koji Kawakami has received research funds from AstraZeneca K.K., Eisai Co., Ltd., Kyowa Kirin Co., Ltd., OMRON Corporation, and Toppan Inc.; consulting fees from Advanced Medical Care Inc., JMDC Inc., LEBER Inc., Ubicom Holdings, Inc., Santen Pharmaceutical Co., Ltd., and Shin Nippon Biomedical Laboratories Ltd.; executive compensation from Cancer Intelligence Care Systems, Inc. and Mytreya Inc.; honoraria from Kyoto University Original Co., Ltd., Pharma Business Academy Ltd., Shionogi & Co., Ltd., Taisho Pharmaceutical Co., Ltd., and SANSHO Co., Ltd. The other authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the Institutional Review Board of Kyoto University Hospital (approval number: R3254).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The requirement for informed consent was waived because the data were anonymized by the provider.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}